PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-13.72%
Revenue decline while CRWD shows 5.94% growth. Joel Greenblatt would examine competitive position erosion.
-21.78%
Cost reduction while CRWD shows 7.31% growth. Joel Greenblatt would examine competitive advantage.
-8.01%
Gross profit decline while CRWD shows 5.45% growth. Joel Greenblatt would examine competitive position.
6.62%
Margin expansion while CRWD shows decline. John Neff would investigate competitive advantages.
2.76%
R&D growth 50-75% of CRWD's 3.75%. Bruce Berkowitz would examine spending effectiveness.
9.83%
G&A growth 1.25-1.5x CRWD's 7.72%. Martin Whitman would scrutinize overhead control.
-13.99%
Marketing expense reduction while CRWD shows 1.68% growth. Joel Greenblatt would examine competitive risk.
-250.00%
Other expenses reduction while CRWD shows 0.00% growth. Joel Greenblatt would examine efficiency.
-4.71%
Operating expenses reduction while CRWD shows 3.48% growth. Joel Greenblatt would examine advantage.
-14.19%
Total costs reduction while CRWD shows 4.38% growth. Joel Greenblatt would examine advantage.
10.03%
Interest expense growth while CRWD reduces costs. John Neff would investigate differences.
10.56%
D&A growth while CRWD reduces D&A. John Neff would investigate differences.
-12.33%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
6.47%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
-12.33%
Operating income decline while CRWD shows 9.37% growth. Joel Greenblatt would examine position.
1.61%
Operating margin growth below 50% of CRWD's 14.45%. Michael Burry would check for structural issues.
-44.44%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
-13.99%
Pre-tax income decline while CRWD shows 20.26% growth. Joel Greenblatt would examine position.
-0.31%
Pre-tax margin decline while CRWD shows 24.73% growth. Joel Greenblatt would examine position.
52.93%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
-25.15%
Net income decline while CRWD shows 29.52% growth. Joel Greenblatt would examine position.
-13.25%
Net margin decline while CRWD shows 33.47% growth. Joel Greenblatt would examine position.
-23.81%
EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-24.19%
Diluted EPS decline while CRWD shows 29.55% growth. Joel Greenblatt would examine position.
-0.87%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.82%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.